Jefferies Downgrades Acadia Pharmaceuticals (ACAD) to Hold

April 6, 2021 4:52 AM EDT
Get Alerts ACAD Hot Sheet
Price: $20.87 -2.79%

Rating Summary:
    10 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 10 | New: 17
Trade Now! 
Join SI Premium – FREE

Jefferies analyst Chris Howerton downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Buy to Hold with a price target of $21.00 (from $40.00).

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $21.18 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades